Stratification of Liver Stiffness according to eGFR in the MAFLD group.

Stratification of Liver Stiffness according to eGFR in the MAFLD group.

<p>Stratification of Liver Stiffness according to eGFR in the MAFLD group.</p>

Збережено в:

Бібліографічні деталі
Автор:	Zienab M. Saad (22676502) (author)
Інші автори:	Hesham K. H. Keryakos (22676505) (author), Hala A. Hassanin (22676508) (author), Mahmoud M. Higazi (22676511) (author), Manar M. Sayed (22676514) (author), Doaa E. Ismail (22676517) (author), Safaa M. Abdelhalim (21398199) (author)
Опубліковано:	2025
Предмети:	Medicine Cell Biology Biotechnology Marine Biology Cancer Infectious Diseases Virology shear wave elastography patients remains underexplored mitigate progression risks higher liver stiffness 56 ± 17 43 ± 17 5 ± 28 ></ b >). ></ b >), ></ b >) shared metabolic abnormalities 9 ± 39 invasive fibrosis scores 45 ± 1 2 ± 5 mafld patients also dialysis ckd patients 108 ckd patients metabolic risk factors 5 ± 6 9 ± 1 5 ± 3 6 ± 1 xlink "> mafld xlink "> 5 %, b >< metabolic dysfunction 9 ml risk populations fibrosis severity advanced fibrosis 1 years 2 vs ckd severity 1 vs 6 vs study aimed sectional study participants stratified older age nafld score management strategies lower egfr integrated screening insulin resistance findings highlight diagnostic criteria bidirectional relationship apri score
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

eGFR in the study participants.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Medication-inclusive multivariable logistic regression for MAFLD.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Multivariable logistic regression models for MAFLD predictors.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Liver Stiffness and Fibrosis Grading by MAFLD Status.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Proposed pathophysiological crosstalk between MAFLD and CKD.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years).
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years).
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Comparison of Non-invasive Liver Fibrosis Scores.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Demographic and Clinical Characteristics of Study Participants.
за авторством: Zienab M. Saad (22676502)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
за авторством: Yan-Ping Zhang (432349)
Опубліковано: (2025)

Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial:aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Association between Exposures of Interest with Serum Lipopolysaccharide and Troponin Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Association between Exposures of Interest with Serum Cytokine Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Descriptive Statistics of Serum Concentrations of Cytokines, Lipopolysaccharides and Cardiac Troponin by Severity Stage in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Characteristics of children with SCD participating in the study, SSCAC, Elobeid, North Kordofan, Sudan, 2023, N: 123.
за авторством: Weaam Abdallah (22683205)
Опубліковано: (2025)

Characteristics of parents of children with SCD participating in the study, SSCAC, Elobeid, North Kordofan, Sudan, 2023, N: 123.
за авторством: Weaam Abdallah (22683205)
Опубліковано: (2025)

Baseline characteristics of caregivers of children with SCD participating in the study, SSCAC, Elobeid, North Kordofan, Sudan, 2023, N: 123.
за авторством: Weaam Abdallah (22683205)
Опубліковано: (2025)

Distribution of Zarit burden scale items across caregivers of children with SCD, SSCAC, Elobeid, North Kordofan, Sudan, 2023, N: 123.
за авторством: Weaam Abdallah (22683205)
Опубліковано: (2025)

Tribal affiliation of parents of children with SCD participating in the study, SSCAC, Elobeid, North Kordofan, Sudan, 2023, N: 123.
за авторством: Weaam Abdallah (22683205)
Опубліковано: (2025)

Table 1_Association of triglyceride-glucose index and remnant cholesterol levels with liver fibrosis progression and disease severity in patients with non-alcoholic fatty liver disease: a cross-sectional study.docx
за авторством: Qiong Duan (4693000)
Опубліковано: (2025)

Parameter values for four-pathway synaptic plasticity model.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Ion channels and membrane properties.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Distal LTP induced by simulated rMS is sustained by sodium dendritic spikes but less affected by inhibition than local electrical stimulation.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Voltage traces from local electrical and rMS TBS, recorded at the soma and distal apical tuft, account for the outcomes of synaptic plasticity.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

The synaptic plasticity model reproduces distal LTP for local electric TBS and predicts proximal and distal LTP for rMS TBS.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Pharmacology in silico: rMS-induced LTP depends on dendritic sodium and calcium through voltage-gated calcium channels, as well as synaptic NMDA channels.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Presynaptic and postsynaptic weights change monotonically linearly over stimulus duration.
за авторством: Nicholas Hananeia (22683665)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_48fl1v72krf1d28dvi5jtirm7p